Department of Neurology, Taizhou First People's Hospital, Zhejiang, China.
PLoS One. 2022 Oct 26;17(10):e0274503. doi: 10.1371/journal.pone.0274503. eCollection 2022.
We aimed to examine the association of CSF tumor necrosis factor-alpha (TNFα) with conversion from mild cognitive impairment (MCI) to dementia. At baseline, there were a total of 129 participants with MCI in this study. The association of CSF TNFα levels with the incidence of dementia were evaluated using Cox proportional hazards regression analysis adjusted for potential confounders. Individuals were categorized into groups based on the CSF TNFα tertiles. Compared to the low group (the reference group), the intermediate group progressed more rapidly to dementia [HR (95% CI) = 2.2 (1.15-4.1); p = 0.016] after adjusting for other covariates. However, the high group did not progress faster than the low group [HR (95% CI) = 1.5 (0.79-2.8); p = 0.214]. Our study suggested a potential non-relationship between CSF TNFα levels and the risk of development of dementia among MCI older people.
我们旨在研究脑脊液肿瘤坏死因子-α(TNFα)与从轻度认知障碍(MCI)向痴呆的转化之间的关联。在基线时,本研究共有 129 名 MCI 参与者。使用 Cox 比例风险回归分析评估 CSF TNFα 水平与痴呆发生率的关联,调整了潜在混杂因素。根据 CSF TNFα 三分位将个体分为不同的组。与低组(参考组)相比,中间组在调整其他协变量后更快地进展为痴呆[HR(95%CI)=2.2(1.15-4.1);p=0.016]。然而,高组并没有比低组进展得更快[HR(95%CI)=1.5(0.79-2.8);p=0.214]。我们的研究表明,在 MCI 老年人中,CSF TNFα 水平与痴呆发展风险之间可能没有关系。